BRCA1-associated tumours are more likely to be estrogen receptor (ER), progesterone receptor (PR) and HER2 negative and to harbor mutations in the TP53 gene than age-matched sporadic breast cancers [15,16]. The gene discussed is BRCA1; the disease is breast cancer.